Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:55 PM
Ignite Modification Date:
2025-12-24 @ 11:55 PM
NCT ID:
NCT07029451
Eligibility Criteria:
Inclusion Criteria:
* Women who meet all the following criteria are eligible for participation:
* At least 20 years of age (including the 20th birthday) when signing informed consent
* Prescribed REKOVELLE for the first time in controlled ovarian stimulation for in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycles
* Willing and able to provide written informed consent
Exclusion Criteria:
* Women who meet any of the following criteria are not eligible for participation:
* Previously undergone more than 1 controlled ovarian stimulation cycles for IVF or ICSI
* Currently participating in an interventional clinical study for which treatment with medication is mandated
* Currently undergoing ovarian stimulation for fertility preservation or oocytes donation
* Contraindications for the use of REKOVELLE
Sex:
FEMALE
Minimum Age:
20 Years
Study:
NCT07029451
Study Brief:
Protocol Section:
NCT07029451